{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "3668557", "DateCompleted": {"Year": "1987", "Month": "11", "Day": "27"}, "DateRevised": {"Year": "2019", "Month": "09", "Day": "03"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "0163-3864", "JournalIssue": {"Volume": "50", "Issue": "3", "PubDate": {"Year": "1987", "Season": "May-Jun"}}, "Title": "Journal of natural products", "ISOAbbreviation": "J Nat Prod"}, "ArticleTitle": "Antineoplastic agents, 122. Constituents of Combretum caffrum.", "Pagination": {"StartPage": "386", "EndPage": "391", "MedlinePgn": "386-91"}, "Abstract": {"AbstractText": ["An investigation of the South African tree Combretum caffrum (Combretaceae) for antineoplastic constituents was conducted by employing the astrocytoma bioassay (9ASK). By this approach and a combination of solvent partition, steric exclusion, and adsorption chromatographic procedures, a substance designated combretastatin [1a] was isolated and found to display significant (71-90% astrocyte reversal at 1-100 micrograms/ml dose levels) astrocyte reversal and murine P-388 lymphocytic leukemia (PS) cell growth inhibition (ED50 0.011 micrograms/ml). The structure of (-)-combretastatin was elucidated by X-ray crystal structure analysis and confirmed by total synthesis. The absolute configuration at C-10 was assigned the R-configuration on the basis of Horeau esterification techniques. Other prominent, albeit PS-inactive, constituents were found to be 3,3',4'-tri-O-methylellagic acid [2] and acacetin [3]."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Cancer Research Institute, Arizona State University, Tempe 85287."}], "LastName": "Pettit", "ForeName": "G R", "Initials": "GR"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Cragg", "ForeName": "G M", "Initials": "GM"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Singh", "ForeName": "S B", "Initials": "SB"}], "GrantList": [{"GrantID": "CA-30311-01A3", "Acronym": "CA", "Agency": "NCI NIH HHS", "Country": "United States"}, {"GrantID": "N01-CM-97262", "Acronym": "CM", "Agency": "NCI NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't", "Research Support, U.S. Gov't, Non-P.H.S.", "Research Support, U.S. Gov't, P.H.S."]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "J Nat Prod", "NlmUniqueID": "7906882", "ISSNLinking": "0163-3864"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents, Phytogenic"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["analysis"], "DescriptorName": "Antineoplastic Agents, Phytogenic"}, {"QualifierName": [], "DescriptorName": "Circular Dichroism"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Leukemia P388"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": ["analysis"], "DescriptorName": "Plant Extracts"}, {"QualifierName": ["analysis"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "South Africa"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1987", "Month": "5", "Day": "1"}, {"Year": "1987", "Month": "5", "Day": "1", "Hour": "0", "Minute": "1"}, {"Year": "1987", "Month": "5", "Day": "1", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["3668557", "10.1021/np50051a008"]}}]}